PEN
Penumbra, Inc.
NYSEUSDEQUITY
Healthcare
DELAYED
Neutral
-5/100
Last price
317.05
▼ 0.06 (0.02%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
317.10
Prev close
317.11
Day high
318.01
Day low
316.87
Volume
308.41K
Market cap
$12.49B
P/E (TTM)
77.90
52W range
221.26 – 362.41
Day trading desk
Gap from prior close
-0.00%
Prior close 317.11
VWAP
317.27
-0.07% from price
Relative volume
2.03×
Unusually busy
Session range
0.36%
316.87 – 318.01
Position in range
16%
Near session low
ATR (14D)
1.42
0.45% of price
Prior day high
318.47
PDH
Prior day low
317.10
PDL
Bid / ask spread
—
Quote not published
Session volume
697.36K
Avg 343.09K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-0.57%
-2.5%
1M
-1.59%
-2.7%
3M
-0.07%
-4.6%
6M
-3.91%
-22.1%
YTD
+1.97%
-12.3%
1Y
+23.82%
+7.4%
3Y
+31.06%
-51.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on PEN open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
1.14M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 17, 26 | NARAYAN SHRUTHI President |
STOCK | 3.06K | $0 | Direct |
| May 19, 26 | ELSESSER ADAM Chief Executive Officer |
STOCK | 77.00K | $0 | Indirect |
| Apr 2, 26 | GREWAL HARPREET SINGH Director |
SELL | 100 | $32.82K | Direct |
| Mar 2, 26 | YUEN MAGGIE S. Chief Financial Officer |
SELL | 2.43K | $832.47K | Direct |
| Feb 17, 26 | ROBERTS JOHANNA General Counsel |
STOCK | 5.26K | $0 | Direct |
| Feb 17, 26 | YUEN MAGGIE S. Chief Financial Officer |
STOCK | 5.26K | $0 | Direct |
| Feb 17, 26 | SHIU LAMBERT Officer |
STOCK | 4.60K | $0 | Direct |
| Feb 17, 26 | NARAYAN SHRUTHI President |
STOCK | 5.26K | $0 | Direct |
| Feb 13, 26 | GREWAL HARPREET SINGH Director |
STOCK | 589 | $0 | Direct |
| Feb 13, 26 | WILDER THOMAS C III Director |
STOCK | 589 | $0 | Direct |
| Feb 13, 26 | BOSE ARANI Director |
STOCK | 589 | $0 | Direct |
| Feb 13, 26 | O'ROURKE BRIDGET A Director |
STOCK | 589 | $0 | Direct |
| Feb 13, 26 | LEEDS JANET Director |
STOCK | 589 | $0 | Direct |
| Feb 13, 26 | SARNA SURBHI Director |
STOCK | 589 | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BOSE ARANI |
Director | 259.61K | Stock Award(Grant) |
ELSESSER ADAM |
Chief Executive Officer | — | Stock Gift |
GREWAL HARPREET SINGH |
Director | 8.72K | Sale |
KASSING DON W |
Director | 9.91K | Stock Award(Grant) |
LEEDS JANET |
Director | 6.64K | Stock Award(Grant) |
NARAYAN SHRUTHI |
President | 33.88K | Stock Award(Grant) |
O'ROURKE BRIDGET A |
Director | 5.96K | Stock Award(Grant) |
ROBERTS JOHANNA |
General Counsel | 67.48K | Stock Award(Grant) |
SHIU LAMBERT |
Officer | 39.77K | Stock Award(Grant) |
YUEN MAGGIE S. |
Chief Financial Officer | 18.35K | Sale |
Fundamentals
Market cap$12.49B
Enterprise value$12.04B
Revenue (TTM)$1.50B
Gross profit$1.02B
EBITDA$204.28M
Net income$160.59M
EPS (TTM)$4.07
Free cash flow$161.10M
Total cash$658.80M
Total debt$212.71M
Book value / share$38.86
Shares outstanding39.39M
Float38.27M
Short % of float5.27%
Dividend yield0.00%
Beta (5Y)0.70
Valuation & profitability ratios
Trailing P/E77.90
Forward P/E51.70
PEG ratio3.57
Price / sales—
Price / book8.16
EV / revenue8.00
EV / EBITDA58.95
Gross margin67.84%
Operating margin10.52%
Profit margin10.67%
Return on equity11.37%
Return on assets6.42%
Debt / equity13.90
Current ratio5.75
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.40B | $1.19B | $1.06B | $847.13M | +17.5% |
| Operating revenue | $1.40B | $1.19B | $1.06B | $847.13M | +17.5% |
| Cost of revenue | $461.23M | $439.62M | $375.88M | $311.93M | +4.9% |
| Gross profit | $942.44M | $755.00M | $682.64M | $535.21M | +24.8% |
| Research & development | $89.77M | $94.78M | $84.42M | $79.41M | -5.3% |
| Selling, general & admin | $663.42M | $573.99M | $506.45M | $449.72M | +15.6% |
| Total operating expense | $753.19M | $668.77M | $590.88M | $529.13M | +12.6% |
| Operating income | $189.25M | $86.22M | $91.77M | $6.08M | +119.5% |
| Net interest income | $14.98M | $12.27M | $5.09M | $137.00K | +22.1% |
| Pre-tax income | $205.13M | $20.87M | $79.65M | $3.89M | +882.9% |
| Tax provision | $27.44M | $6.86M | -$11.30M | $5.89M | +300.1% |
| Net income | $177.69M | $14.01M | $90.95M | -$2.00M | +1,168.1% |
| Net income to common | $177.69M | $14.01M | $90.95M | -$2.00M | +1,168.1% |
| Basic EPS | 4.57 | 0.36 | 2.37 | -0.05 | +1,169.4% |
| Diluted EPS | 4.52 | 0.36 | 2.32 | -0.05 | +1,155.6% |
| EBIT | $206.44M | $22.29M | $81.39M | $5.64M | +826.3% |
| EBITDA | $223.91M | $45.99M | $108.65M | $29.96M | +386.9% |
| Basic shares | 38.92M | 38.63M | 38.40M | 37.84M | +0.7% |
| Diluted shares | 39.29M | 39.27M | 39.22M | 37.84M | +0.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $186.90M | $324.40M | $167.49M | $69.86M | -42.4% |
| Cash & short-term investments | $544.82M | $340.13M | $289.19M | $188.03M | +60.2% |
| Accounts receivable | $190.02M | $167.67M | $201.77M | $203.38M | +13.3% |
| Inventory | $431.55M | $406.74M | $388.02M | $334.01M | +6.1% |
| Total current assets | $1.22B | $951.13M | $915.40M | $755.70M | +27.9% |
| Property, plant & equipment | $316.35M | $267.76M | $280.50M | $280.41M | +18.1% |
| Goodwill & intangibles | $173.58M | $173.02M | $249.37M | $257.77M | +0.3% |
| Total assets | $1.83B | $1.53B | $1.56B | $1.37B | +19.1% |
| Total current liabilities | $183.13M | $158.34M | $151.14M | $144.93M | +15.7% |
| Total debt | $219.70M | $223.39M | $234.34M | $235.77M | -1.7% |
| Total liabilities | $398.92M | $382.25M | $377.36M | $372.03M | +4.4% |
| Retained earnings | $237.69M | $60.00M | $134.86M | $43.90M | +296.1% |
| Shareholder equity | $1.43B | $1.15B | $1.18B | $998.86M | +24.0% |
| Working capital | $1.03B | $792.78M | $764.26M | $610.77M | +30.4% |
| Net tangible assets | $1.25B | $977.91M | $929.58M | $741.09M | +28.2% |
| Shares issued | 39.23M | 38.49M | 38.68M | 38.11M | +1.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $177.69M | $14.01M | $90.95M | -$2.00M | +1,168.1% |
| Depreciation & amortisation | $17.47M | $23.70M | $27.26M | $24.32M | -26.3% |
| Stock-based compensation | $59.21M | $46.16M | $50.52M | $37.38M | +28.3% |
| Change in working capital | -$42.72M | -$23.78M | -$79.08M | -$121.53M | -79.6% |
| Operating cash flow | $238.66M | $168.48M | $97.33M | -$55.66M | +41.7% |
| Capital expenditure | -$63.73M | -$21.18M | -$15.21M | -$19.30M | -200.9% |
| Investing cash flow | -$404.59M | $77.62M | -$16.08M | $54.79M | -621.2% |
| Share buybacks | $0 | -$100.39M | $0 | $0 | +100.0% |
| Financing cash flow | $26.53M | -$87.01M | $16.20M | $11.62M | +130.5% |
| Free cash flow | $174.93M | $147.30M | $82.12M | -$74.96M | +18.8% |
| End cash position | $186.90M | $324.40M | $167.49M | $69.86M | -42.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $390.05M | $374.76M | $385.38M | $354.69M | $339.45M | +4.1% |
| Operating revenue | $390.05M | $374.76M | $385.38M | $354.69M | $339.45M | +4.1% |
| Cost of revenue | $125.10M | $121.35M | $123.26M | $114.27M | $115.44M | +3.1% |
| Gross profit | $264.94M | $253.41M | $262.13M | $240.42M | $224.01M | +4.6% |
| Research & development | $25.40M | $22.38M | $21.79M | $22.68M | $23.22M | +13.5% |
| Selling, general & admin | $198.51M | $192.79M | $181.10M | $168.90M | $159.96M | +3.0% |
| Total operating expense | $223.91M | $215.18M | $202.90M | $191.58M | $183.18M | +4.1% |
| Operating income | $41.04M | $38.23M | $59.23M | $48.84M | $40.83M | +7.3% |
| Net interest income | $5.60M | $4.55M | $4.23M | $4.02M | $3.67M | +23.1% |
| Pre-tax income | $46.19M | $41.69M | $63.63M | $52.33M | $45.31M | +10.8% |
| Tax provision | $11.38M | $9.10M | $16.29M | $6.47M | $40.00K | +25.0% |
| Net income | $34.81M | $32.58M | $47.34M | $45.85M | $45.27M | +6.8% |
| Net income to common | $34.81M | $32.58M | $47.34M | $45.85M | $45.27M | +6.8% |
| Basic EPS | 0.88 | 0.83 | 1.21 | 1.17 | 1.15 | +6.0% |
| Diluted EPS | 0.88 | 0.82 | 1.20 | 1.17 | 1.15 | +7.3% |
| EBIT | $46.50M | $42.01M | $63.97M | $52.66M | $45.63M | +10.7% |
| EBITDA | $52.11M | $46.58M | $68.43M | $55.15M | $51.14M | +11.9% |
| Basic shares | 39.35M | 39.28M | 39.19M | 39.08M | 38.83M | +0.2% |
| Diluted shares | 39.57M | 39.54M | 39.39M | 39.30M | 39.25M | +0.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $205.27M | $241.29M | $186.90M | $321.03M | $421.77M | -14.9% |
| Cash & short-term investments | $658.79M | $615.66M | $544.82M | $470.30M | $424.56M | +7.0% |
| Accounts receivable | $190.41M | $183.29M | $190.02M | $183.43M | $175.54M | +3.9% |
| Inventory | $442.65M | $438.54M | $431.55M | $432.37M | $427.63M | +0.9% |
| Total current assets | $1.34B | $1.28B | $1.22B | $1.14B | $1.07B | +5.4% |
| Property, plant & equipment | $338.27M | $329.54M | $316.35M | $295.24M | $286.49M | +2.6% |
| Goodwill & intangibles | $172.26M | $172.53M | $173.58M | $173.12M | $173.30M | -0.2% |
| Total assets | $1.97B | $1.90B | $1.83B | $1.74B | $1.67B | +4.0% |
| Total current liabilities | $233.78M | $211.73M | $183.13M | $169.60M | $157.76M | +10.4% |
| Total debt | $212.71M | $216.18M | $219.70M | $217.04M | $220.53M | -1.6% |
| Total liabilities | $443.96M | $424.63M | $398.92M | $385.67M | $380.86M | +4.6% |
| Retained earnings | $305.09M | $270.27M | $237.69M | $190.35M | $144.50M | +12.9% |
| Shareholder equity | $1.53B | $1.47B | $1.43B | $1.36B | $1.29B | +3.9% |
| Working capital | $1.11B | $1.06B | $1.03B | $971.92M | $907.72M | +4.4% |
| Net tangible assets | $1.36B | $1.30B | $1.25B | $1.19B | $1.12B | +4.4% |
| Shares issued | 39.39M | 39.32M | 39.23M | 39.15M | 38.97M | +0.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $34.81M | $32.58M | $47.34M | $45.85M | $45.27M | +6.8% |
| Depreciation & amortisation | $5.62M | $4.57M | $4.46M | $2.49M | $5.51M | +22.8% |
| Stock-based compensation | $13.66M | $14.64M | $15.26M | $15.93M | $14.23M | -6.7% |
| Change in working capital | -$8.27M | $35.47M | $3.56M | -$22.00M | -$14.28M | -123.3% |
| Operating cash flow | $46.08M | $86.97M | $86.48M | $58.26M | $44.95M | -47.0% |
| Capital expenditure | -$13.54M | -$13.67M | -$18.43M | -$16.25M | -$15.58M | +0.9% |
| Investing cash flow | -$91.09M | -$30.63M | -$225.65M | -$162.86M | -$15.58M | -197.4% |
| Share buybacks | — | — | $0 | — | — | — |
| Financing cash flow | $9.03M | -$1.91M | $5.06M | $3.95M | $14.82M | +573.3% |
| Free cash flow | $32.54M | $73.30M | $68.05M | $42.01M | $29.37M | -55.6% |
| End cash position | $205.27M | $241.29M | $186.90M | $321.03M | $421.77M | -14.9% |
Options analytics
Put / call volume
2.50
Put-heavy session
Put / call open interest
2.09
Positioning, not flow
Max pain
380.00
+19.9% from spot
ATM implied vol
18.0%
Nearest strike to spot
Skew (10% OTM)
+47.3%
Puts bid over calls
Call volume
165
Contracts, this expiry
Put volume
413
Contracts, this expiry
Heaviest call OI
450.00
247 contracts
Heaviest put OI
170.00
265 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 1.18 | 1.01 | -14.4% |
| Mar 2026 | 1.06 | 1.01 | -4.6% |
| Dec 2025 | 1.11 | 1.18 | +6.1% |
| Sep 2025 | 0.92 | 0.97 | +5.3% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 1.18 | 7 | $400.14M | +12.8% |
| Next quarter | 1.49 | 7 | $428.35M | +11.1% |
| Current year | 4.79 | 11 | $1.59B | +13.5% |
| Next year | 6.13 | 13 | $1.80B | +13.0% |
Analyst targets & ownership
Mean target$361.58
High target$374.00
Low target$320.00
Implied upside14.05%
Analyst count12
ConsensusHOLD
Strong buy / Buy1 / 2
Hold13
Sell / Strong sell0 / 0
Held by insiders2.90%
Held by institutions88.33%
Institutions holding589
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
318.41
-0.43% from price
SMA 20
318.53
-0.46% from price
SMA 50
321.54
-1.40% from price
SMA 100
320.49
-1.07% from price
SMA 200
326.92
-3.02% from price
EMA 12
318.26
-0.38% from price
EMA 26
319.27
-0.70% from price
EMA 50
320.19
-0.98% from price
RSI (14)
37.4
Neutral
MACD (12,26,9)
-1.02
Hist -0.08
ATR (14)
1.42
0.45% of price
Realised vol 30D
5.4%
Annualised
Bollinger upper
320.22
20, 2σ
Bollinger lower
316.84
20, 2σ
50 / 200 cross
Death
321.54 vs 326.92
Trend bias
Below 200
-3.02%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.01
Less volatile than market
Correlation to SPY
0.01
Largely independent
Realised vol 30D
5.4%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-13.7%
Peak to trough
Max drawdown 5Y
-59.7%
Peak to trough
ATR 14
1.42
0.45% of price
Beta (reported)
0.70
5Y monthly, from filing
Short interest
Shares short
1.81M
Prior 1.82M
Change vs prior
-0.7%
Shorts covering
% of float
5.27%
Normal
% of shares out
4.58%
Against total outstanding
Days to cover
6.7
Crowded exit
Float
38.27M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 6, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
| Jun 11, 26 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
| May 7, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| May 7, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
| Feb 26, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
| Jan 20, 26 | RBC Capital | DOWNGRADE | Outperform | Sector Perform |
| Jan 20, 26 | Canaccord Genuity | DOWNGRADE | Buy | Hold |
| Jan 16, 26 | Jefferies | DOWNGRADE | Buy | Hold |
| Jan 16, 26 | Needham | DOWNGRADE | Buy | Hold |
| Jan 16, 26 | Citigroup | DOWNGRADE | Buy | Neutral |
| Jan 16, 26 | Leerink Partners | DOWNGRADE | Outperform | Market Perform |
| Jan 16, 26 | Baird | DOWNGRADE | Outperform | Neutral |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-07-30
Corporate Changes & Voting Matters
8-K · 2026-06-22
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-05-29
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425 · 2026-05-07
Periodic Financial Reports
10-Q · 2026-05-06
Annual Report to Shareholders
ARS · 2026-04-29
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425 · 2026-04-23
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425 · 2026-04-22
Headlines
New STORM-PE Data Demonstrate Correlation Between Clinical Assessments and Real-world Functional Recovery Captured Through Wearable Technology in Patients with Pulmonary Embolism
PR Newswire · 13h ago
IART vs. PEN: Which Stock Is the Better Value Option?
Zacks · 5d ago
IART or PEN: Which Is the Better Value Stock Right Now?
Zacks · 7d ago
Reasons to Retain Penumbra Stock in Your Portfolio for Now
Zacks · 21d ago
TFX vs. PEN: Which Stock Is the Better Value Option?
Zacks · 25d ago
TFX or PEN: Which Is the Better Value Stock Right Now?
Zacks · 41d ago
Which Medtech Giant Would Buy Inspire Medical Systems?
Trefis · 53d ago
TFX vs. PEN: Which Stock Is the Better Value Option?
Zacks · 57d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.